Bionik understands the importance of working collaboratively and strives to build long-term strategic relationships. Along with the continued development of our earlier stage research programs, Bionik is dedicated to expanding its pipeline through a robust growth strategy focused on the acquisition and in-licensing of synergistic products and technologies.

Our robust growth strategy is focused on:

  • Leveraging internal expertise and broad network to develop new synergistic technologies
  • Team dedicated to expanding product pipeline through strategic partnering and acquisitions with products and enabling software

Expamd and focused development programs

If you would like to learn more about partnering with Bionik, please contact Michal Prywata, Co-Founder and Chief Technology Officer at